ArticleClinical & experimental metastasis2019

Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.

Shiue-Wei Lai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.